Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Characterizing affinity epitopes between prion protein and β-amyloid using an epitope mapping immunoassay.

Kang M, Kim SY, An SS, Ju YR.

Exp Mol Med. 2013 Aug 2;45:e34. doi: 10.1038/emm.2013.63. Erratum in: Exp Mol Med. 2014;46:e96.

2.

High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.

Dohler F, Sepulveda-Falla D, Krasemann S, Altmeppen H, Schlüter H, Hildebrand D, Zerr I, Matschke J, Glatzel M.

Brain. 2014 Mar;137(Pt 3):873-86. doi: 10.1093/brain/awt375. Epub 2014 Feb 10.

3.

Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus.

Li R, Liu T, Wong BS, Pan T, Morillas M, Swietnicki W, O'Rourke K, Gambetti P, Surewicz WK, Sy MS.

J Mol Biol. 2000 Aug 18;301(3):567-73.

PMID:
10966770
4.

Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein.

Parkin ET, Watt NT, Hussain I, Eckman EA, Eckman CB, Manson JC, Baybutt HN, Turner AJ, Hooper NM.

Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11062-7. Epub 2007 Jun 15.

5.

Humoral immune response to fibrillar beta-amyloid peptide.

Miller DL, Currie JR, Mehta PD, Potempska A, Hwang YW, Wegiel J.

Biochemistry. 2003 Oct 14;42(40):11682-92.

PMID:
14529278
6.

[Production of monoclonal antibodies to the prion protein and their characterization].

Oboznaia MB, Vladimirova NM, Titova MA, Volkova TD, Koroev DO, Riabokon' AA, Egorov AA, Rybakov SS, Vol'pina OM.

Bioorg Khim. 2008 Nov-Dec;34(6):754-63. Russian.

PMID:
19088748
7.
8.

Epitope scanning indicates structural differences in brain-derived monomeric and aggregated mutant prion proteins related to genetic prion diseases.

Tapella L, Stravalaci M, Bastone A, Biasini E, Gobbi M, Chiesa R.

Biochem J. 2013 Sep 15;454(3):417-25. doi: 10.1042/BJ20130563.

PMID:
23808898
9.

PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.

Pietri M, Dakowski C, Hannaoui S, Alleaume-Butaux A, Hernandez-Rapp J, Ragagnin A, Mouillet-Richard S, Haik S, Bailly Y, Peyrin JM, Launay JM, Kellermann O, Schneider B.

Nat Med. 2013 Sep;19(9):1124-31. doi: 10.1038/nm.3302. Epub 2013 Aug 18.

PMID:
23955714
10.

The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes.

Polymenidou M, Moos R, Scott M, Sigurdson C, Shi YZ, Yajima B, Hafner-Bratkovic I, Jerala R, Hornemann S, Wuthrich K, Bellon A, Vey M, Garen G, James MN, Kav N, Aguzzi A.

PLoS One. 2008;3(12):e3872. doi: 10.1371/journal.pone.0003872. Epub 2008 Dec 8.

11.

Prion protein in Alzheimer's pathogenesis: a hot and controversial issue.

Benilova I, De Strooper B.

EMBO Mol Med. 2010 Aug;2(8):289-90. doi: 10.1002/emmm.201000088.

12.

Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells.

Gilch S, Wopfner F, Renner-Müller I, Kremmer E, Bauer C, Wolf E, Brem G, Groschup MH, Schätzl HM.

J Biol Chem. 2003 May 16;278(20):18524-31. Epub 2003 Mar 11.

13.

Cellular prion protein modulates β-amyloid deposition in aged APP/PS1 transgenic mice.

Ordóñez-Gutiérrez L, Torres JM, Gavín R, Antón M, Arroba-Espinosa AI, Espinosa JC, Vergara C, Del Río JA, Wandosell F.

Neurobiol Aging. 2013 Dec;34(12):2793-804. doi: 10.1016/j.neurobiolaging.2013.05.019. Epub 2013 Jul 4.

PMID:
23831375
14.

Neurotoxicity of beta-amyloid and prion peptides.

Forloni G.

Curr Opin Neurol. 1996 Dec;9(6):492-500. Review.

PMID:
9007411
15.

Characterization of the prion protein 3F4 epitope and its use as a molecular tag.

Lund C, Olsen CM, Tveit H, Tranulis MA.

J Neurosci Methods. 2007 Sep 30;165(2):183-90. Epub 2007 Jun 13.

PMID:
17644183
16.

Pathway complexity of prion protein assembly into amyloid.

Baskakov IV, Legname G, Baldwin MA, Prusiner SB, Cohen FE.

J Biol Chem. 2002 Jun 14;277(24):21140-8. Epub 2002 Mar 23.

17.

Cellular prion protein and Alzheimer disease: link to oligomeric amyloid-β and neuronal cell death.

Kudo W, Petersen RB, Lee HG.

Prion. 2013 Mar-Apr;7(2):114-6. doi: 10.4161/pri.22848. Epub 2012 Nov 15.

18.

Generation of antibodies against bovine recombinant prion protein in various strains of mice.

Andrievskaia O, McRae H, Elmgren C, Huang H, Balachandran A, Nielsen K.

Clin Vaccine Immunol. 2006 Jan;13(1):98-105.

19.

The neurodegeneration in Alzheimer disease and the prion protein.

Forloni G, Sclip A, Borsello T, Balducci C.

Prion. 2013 Jan-Feb;7(1):60-5. doi: 10.4161/pri.23286. Epub 2013 Jan 1. Review.

20.

Modeling amyloid-beta as homogeneous dodecamers and in complex with cellular prion protein.

Gallion SL.

PLoS One. 2012;7(11):e49375. doi: 10.1371/journal.pone.0049375. Epub 2012 Nov 8.

Items per page

Supplemental Content

Write to the Help Desk